Bausch & Lomb Incorporated

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1992-10-08

Employees: -

Market Cap: -

Website

Clinical Trials

Indomethacin Eyedrops Compared With Ketorolac Eyedrops for Ocular Inflammation Following Cataract Surgery

Phase 4

Completed

Conditions: Cataract
Inflammation

Interventions: Drug: Indomethacin ophthalmic solution
Drug: Ketorolac Ophthalmic Solution

First Posted Date: 2009-05-20

Last Posted Date: 2012-08-13

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 120

Registration Number: NCT00904904

Locations: 🇩🇪
Bausch & Lomb, Berlin, Germany

Evaluation of BOL-303242-X Versus Vehicle for the Treatment of Inflammation Following Cataract Surgery

Phase 2

Completed

Conditions: Cataract
Inflammation

Interventions: Drug: BOL-303242-X
Drug: Vehicle for BOL-303242-X

First Posted Date: 2009-05-20

Last Posted Date: 2020-09-22

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 415

Registration Number: NCT00905450

Locations: 🇺🇸
Bausch & Lomb, Rochester, New York, United States

One-Day Dispensing Clinical Evaluation of SofLens Daily Disposable Lenses Compared to a Marketed 1 Day Contact Lens

Not Applicable

Completed

Conditions: Myopia

Interventions: Device: SofLens Daily Disposable
Device: Marketed 1 Day Contact Lens

First Posted Date: 2009-05-15

Last Posted Date: 2015-03-02

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 28

Registration Number: NCT00902850

Locations: 🇺🇸
Bausch & Lomb Research Clinic, Rochester, New York, United States

Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery

Phase 3

Completed

Conditions: Pain
Inflammation

Interventions: Drug: Placebo Comparator
Drug: Bromfenac Ophthalmic Solution

First Posted Date: 2009-03-02

Last Posted Date: 2013-01-25

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 299

Registration Number: NCT00853970

Locations: 🇺🇸
ISTA Pharmaceuticals, Inc., Irvine, California, United States

Study of T-PRED(TM) Compared to Pred Forte(R) II

Phase 3

Completed

Conditions: Cataract

Interventions: Drug: T-Pred
Drug: Pred Forte

First Posted Date: 2009-03-02

Last Posted Date: 2020-10-20

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 172

Registration Number: NCT00854061

Locations: 🇺🇸
ISTA Pharmaceuticals, Inc., Irvine, California, United States

Evaluation of the Safety & Effectiveness of the Bausch & Lomb AKREOS® TL Intraocular Lens

Phase 4

Completed

Conditions: Cataract
Aphakia

Interventions: Device: The Bausch & Lomb Akreos TL IOL (MI60) posterior chamber IOL

First Posted Date: 2009-02-06

Last Posted Date: 2011-12-09

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 125

Registration Number: NCT00838045

Locations: 🇩🇪
Klinikum der J.W. Goethe-Universität, Frankfurt, Germany

Safety and Effectiveness of the Akreos Toric Intraocular Lens.

Phase 4

Completed

Conditions: Cataract
Astigmatism

Interventions: Device: Akreos Toric IOL
Device: Akreos Advanced Optics Aspheric Intraocular Lens (Akreos AO)

First Posted Date: 2009-01-21

Last Posted Date: 2013-03-25

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 198

Registration Number: NCT00825513

Locations: 🇸🇪
Dept. of Clinical Sciences/ Ophthalmology Umea University Hospital, Umea, Sweden

Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects

Phase 1

Completed

Conditions: Cataract Extraction

Interventions: Drug: Besifloxacin hydrochloride
Drug: moxifloxacin hydrochloride
Drug: gatifloxacin

First Posted Date: 2009-01-16

Last Posted Date: 2011-12-13

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 105

Registration Number: NCT00824070

Locations: 🇺🇸
Ophthalmic Consultants of Long Island, Rockville Center, New York, United States

Evaluation of the Safety and Effectiveness of the Akreos MI Five-0 Intraocular Lens.

Not Applicable

Terminated

Conditions: Cataract

Interventions: Device: Akreos MI Five-O

First Posted Date: 2008-12-09

Last Posted Date: 2014-01-17

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 10

Registration Number: NCT00804726

Locations: 🇩🇪
Augenzentrum Maus Wolfsstr 16, Koln, Germany

Clinical Evaluation of a New Aspheric Intraocular Lens.

Phase 4

Completed

Conditions: Cataract

Interventions: Device: Akreos Adapt in fellow operated eye.
Device: Advanced Akreos Adapt in one operated eye.

First Posted Date: 2008-11-06

Last Posted Date: 2011-12-12

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 75

Registration Number: NCT00786565

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy